OFFICIAL PRESS RELEASE
Read more about Biote becoming a public company through the business combination with Haymaker Acquisition Corp. III and what it means for the future of Biote.
BIOTE PRESENTATION AT ICR CONFERENCE
JANUARY 12, 2022
Biote is a hormone optimization company that has translated over 80 years of scientific insight into clinically-validated medical approaches that identify and treat imbalances in the production of hormones. By partnering with over 4,700 medical providers across the United States, Biote is educating practitioners on the scientific evidence of the roles of hormones and supplements to support improved health, and on responsible treatment of patients. We are dedicated to helping patients live better, longer by changing the way healthcare is practiced on a global level.